-
1.发明授权
公开(公告)号：EP0841904B1
公开(公告)日：2003-02-05
申请号：EP96924850.9
申请日：1996-07-02
申请人： ALTANA Pharma AG
CPC分类号： A61K31/60 , A61K9/284 , A61K9/2866 , A61K9/5078 , A61K9/5084 , A61K31/44 , A61K31/47 , A61K31/495 , A61K31/545 , A61K31/555 , A61K31/65 , A61K31/70 , A61K33/245 , A61K31/345 , A61K31/415 , A61K31/42 , A61K31/43 , A61K31/40 , A61K31/165 , A61K31/535 , A61K45/06 , A61K2300/00
摘要： An oral pharmaceutical composition of a reversible proton pump inhibitor in pellet or tablet form, wherein the reversible proton pump inhibitor is at least partly in slow-release form, is distinguished, on combined administration with an antimicrobially-active ingredient, by an enhanced action of rapid onset against disorders caused by Helicobacter.
-
公开(公告)号：EP1624869A2
公开(公告)日：2006-02-15
申请号：EP04741525.2
申请日：2004-05-07
申请人： ALTANA Pharma AG
发明人： ANSTETT-KLEIN, Isabel , DIETRICH, Rango , NEY, Hartmut , SCHILLER, Marc , SCHÄFER-PREUSS, Sabine , HARTMANN, Manfred
CPC分类号： A61K9/2886 , A61K9/2081 , A61K9/5078 , A61K31/44 , A61K31/4439
摘要： Dosage forms for oral administration of the magnesium salt of pantoprazole are described.
-
3.发明公开RAPIDLY DISINTEGRATING TABLET COMPRISING AN ACID-LABILE ACTIVE INGREDIENT 有权用酸不稳定的活性FAST DECAY END TABLET
公开(公告)号：EP1341528A1
公开(公告)日：2003-09-10
申请号：EP01999360.9
申请日：2001-12-06
申请人： ALTANA Pharma AG
发明人： DIETRICH, Rango , LINDER, Rudolf , NEY, Hartmut
CPC分类号： A61K9/2081 , A61K9/1617 , A61K31/4439
摘要： A rapidly disintegrating tablet for oral administration of acid-labile active ingredients is described. The rapidly disintegrating tablet for oral administration of an acid-labile active ingredient comprises a plurality of individual active ingredient units together with pharmaceutical excipients, where the acid-labile active ingredient is present in the individual active ingredient units in a matrix composed of a mixture comprising at least one solid paraffin and one or more substances from the group of fatty alcohol, triglyceride and fatty acid ester, and where excipients which, on oral intake of the tablet, bring about rapid disintegration of the tablet are present.
-
公开(公告)号：EP1799190A1
公开(公告)日：2007-06-27
申请号：EP05794535.4
申请日：2005-09-30
申请人： Altana Pharma AG
IPC分类号： A61K9/00 , A61K31/4439 , A61K31/4375
CPC分类号： A61K31/4439 , A61K9/0056 , A61K9/2081 , A61K9/2095 , A61K9/5026 , A61K9/5078 , A61K31/4375
摘要： The invention relates to novel dosage forms for proton pump antagonists.
-
5.发明公开DOSAGE FORM CONTAINING (S)-PANTOPRAZOLE AS ACTIVE INGREDIENT 有权PHARMACEUTICAL形成含有（S）-pantoprazole作为活性成分的
公开(公告)号：EP1624870A2
公开(公告)日：2006-02-15
申请号：EP04741526.0
申请日：2004-05-07
申请人： ALTANA Pharma AG
发明人： ANSTETT-KLEIN, Isabel , DIETRICH, Rango , HARTMANN, Manfred , NEY, Hartmut , SCHÄFER-PREUSS, Sabine , SCHILLER, Marc
CPC分类号： A61K9/2886 , A61K9/2081 , A61K9/2846 , A61K9/5073 , A61K9/5078 , A61K31/4439
摘要： Dosage forms for oral administration of the magnesium salt of (S)-pantoprazole are described.
-
6.发明授权
公开(公告)号：EP0841903B1
公开(公告)日：2003-02-05
申请号：EP96924849.1
申请日：1996-07-02
申请人： ALTANA Pharma AG
发明人： DIETRICH, Rango , SACHS, George , NEY, Hartmut , BENEDIKT, Gerald
CPC分类号： A61K31/4439 , A61K9/2886 , A61K9/5073 , A61K9/5078 , A61K31/44 , A61K45/06
摘要： An oral pharmaceutical composition of pantoprazole in pellet or tablet form, wherein the pantoprazole is at least partly in slow-release form, is distinguished, on combined administration with an antinicrobially-active ingredient, by an enhanced action of rapid onset against disorders caused by Helicobacter.
-
7.发明公开ORAL PHARMACEUTICAL PREPARATION COMPRISING A PROTON PUMP ANTAGONIST AND A BASIC EXCIPIENT 审中-公开与质子泵拮抗剂和基本的赋形剂的口服药物制剂
公开(公告)号：EP1799211A1
公开(公告)日：2007-06-27
申请号：EP05797200.2
申请日：2005-09-30
申请人： Altana Pharma AG
IPC分类号： A61K31/4375 , A61P1/04 , A61K9/20
CPC分类号： A61K31/4375
摘要： The invention relates to novel extended release dosage forms for reversible proton pump antagonists, comprising a basic excipient.
-
8.发明授权ORAL ADMINISTRATION FORM FOR PYRIDIN-2-YLMETHYLSULFINYL-1H-BENZIMIDAZOLES 无效所述口服剂型是吡啶-2- ylmethylsulfinyl--1H-苯并咪唑类
公开(公告)号：EP1105105B1
公开(公告)日：2006-03-29
申请号：EP99941537.5
申请日：1999-08-07
申请人： ALTANA Pharma AG
发明人： DIETRICH, Rango , NEY, Hartmut
CPC分类号： A61K9/2027 , A61K9/2846
摘要： The invention relates to an oral administration form for pyridin-2-ylmethylsulfinyl-1H-benzimidazoles and their salts, which comprises the active compound together with tablet disintegrants and is provided with a film coating customary per se for sustained-release compositions.
-
9.发明公开ORAL DOSAGE FORM CONTAINING A PDE 4 INHIBITOR AS AN ACTIVE INGREDIENT AND POLYVINYLPYRROLIDON AS EXCIPIENT 有权口服药物剂型包含PDE-4抑制剂主动和聚乙烯醇不是帮助FUEL
公开(公告)号：EP1478399A1
公开(公告)日：2004-11-24
申请号：EP03704652.1
申请日：2003-02-19
申请人： ALTANA Pharma AG
发明人： DIETRICH, Rango , EISTETTER, Klaus , NEY, Hartmut
IPC分类号： A61K45/06 , A61K9/20 , A61K31/166 , A61K31/44 , A61P11/06
CPC分类号： A61K9/0002 , A61K9/0053 , A61K9/20 , A61K9/2013 , A61K9/2018 , A61K9/2027 , A61K9/2054 , A61K9/2059 , A61K31/166 , A61K31/44
摘要： Dosage forms for oral administration of a PDE 4 inhibitor whose solubility is slight are described. They contain PVP as binder.
-
10.发明公开ORAL PHARMACEUTICAL PREPARATION COMPRISING A PROTON PUMP ANTAGONIST AND A BASIC EXCIPIENT 审中-公开与质子泵拮抗剂和基本支持口服药物制剂
公开(公告)号：EP1615624A2
公开(公告)日：2006-01-18
申请号：EP04726521.0
申请日：2004-04-08
申请人： ALTANA Pharma AG
IPC分类号： A61K9/20 , A61K31/4439 , A61K9/28
CPC分类号： A61K9/2009 , A61K9/2054 , A61K9/2866 , A61K31/00 , A61K31/4375
摘要： The invention relates to novel dosage forms for proton pump antagonists.
-
-
-
-
-
-
-
-
-
搜索结果
11 条记录 (耗时 0.011 秒)
